NYSE:ARA - American Renal Associates Stock Price, Price Target & More

$15.77 +0.22 (+1.41 %)
(As of 04/24/2018 04:00 PM ET)
Previous Close$15.55
Today's Range$15.32 - $15.78
52-Week Range$9.91 - $24.07
Volume234,828 shs
Average Volume173,390 shs
Market Capitalization$516.27 million
P/E Ratio25.49
Dividend YieldN/A
Beta1.92

About American Renal Associates (NYSE:ARA)

American Renal Associates logoAmerican Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2017, it owned and operated 228 dialysis clinics in partnership with 401 nephrologist partners treating approximately 15,600 patients in 26 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.

Receive ARA News and Ratings via Email

Sign-up to receive the latest news and ratings for ARA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolNYSE:ARA
CUSIPN/A
Phone978-922-3080

Debt

Debt-to-Equity Ratio4.28%
Current Ratio1.20%
Quick Ratio1.17%

Price-To-Earnings

Trailing P/E Ratio25.49
Forward P/E Ratio21.31
P/E Growth0.76

Sales & Book Value

Annual Sales$745.11 million
Price / Sales0.67
Cash Flow$1.8401 per share
Price / Cash8.57
Book Value$3.83 per share
Price / Book4.12

Profitability

EPS (Most Recent Fiscal Year)$0.61
Net Income$4.85 million
Net Margins-1.00%
Return on Equity14.51%
Return on Assets2.06%

Miscellaneous

Employees4,692
Outstanding Shares31,460,000

How to Become a New Pot Stock Millionaire

American Renal Associates (NYSE:ARA) Frequently Asked Questions

What is American Renal Associates' stock symbol?

American Renal Associates trades on the New York Stock Exchange (NYSE) under the ticker symbol "ARA."

How were American Renal Associates' earnings last quarter?

American Renal Associates (NYSE:ARA) announced its quarterly earnings data on Tuesday, March, 6th. The company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.15 by $0.03. The firm had revenue of $194.40 million for the quarter, compared to analyst estimates of $195.15 million. American Renal Associates had a negative net margin of 1.00% and a positive return on equity of 14.51%. The business's quarterly revenue was down 2.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.26 earnings per share. View American Renal Associates' Earnings History.

When is American Renal Associates' next earnings date?

American Renal Associates is scheduled to release their next quarterly earnings announcement on Monday, May, 7th 2018. View Earnings Estimates for American Renal Associates.

What price target have analysts set for ARA?

3 brokerages have issued 1 year price targets for American Renal Associates' shares. Their predictions range from $20.00 to $27.00. On average, they anticipate American Renal Associates' stock price to reach $23.50 in the next year. View Analyst Ratings for American Renal Associates.

Who are some of American Renal Associates' key competitors?

Who are American Renal Associates' key executives?

American Renal Associates' management team includes the folowing people:
  • Mr. Joseph A. Carlucci, Co-Founder, CEO & Chairman (Age 64)
  • Mr. Syed T. Kamal, Founder, Pres & Director (Age 65)
  • Mr. Jonathan L. Wilcox, CFO & VP (Age 44)
  • Dr. Don E. Williamson M.D., Exec. VP & COO
  • Mr. Jason M. Boucher, VP of Fin., Chief Accounting Officer & Treasurer (Age 46)

When did American Renal Associates IPO?

(ARA) raised $161 million in an initial public offering (IPO) on Thursday, April 21st 2016. The company issued 7,500,000 shares at a price of $20.00-$23.00 per share. BofA Merrill Lynch, Barclays and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Has American Renal Associates been receiving favorable news coverage?

News coverage about ARA stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. American Renal Associates earned a media sentiment score of 0.18 on Accern's scale. They also assigned headlines about the company an impact score of 47.39 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of American Renal Associates?

Shares of ARA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is American Renal Associates' stock price today?

One share of ARA stock can currently be purchased for approximately $15.77.

How big of a company is American Renal Associates?

American Renal Associates has a market capitalization of $516.27 million and generates $745.11 million in revenue each year. The company earns $4.85 million in net income (profit) each year or $0.61 on an earnings per share basis. American Renal Associates employs 4,692 workers across the globe.

How can I contact American Renal Associates?

American Renal Associates' mailing address is 500 CUMMINGS CENTER SUITE 6550, BEVERLY MA, 01915. The company can be reached via phone at 978-922-3080 or via email at [email protected]


MarketBeat Community Rating for American Renal Associates (ARA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  107 (Vote Outperform)
Underperform Votes:  107 (Vote Underperform)
Total Votes:  214
MarketBeat's community ratings are surveys of what our community members think about American Renal Associates and other stocks. Vote "Outperform" if you believe ARA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

American Renal Associates (NYSE:ARA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for American Renal Associates in the last 12 months. Their average twelve-month price target is $23.50, suggesting that the stock has a possible upside of 49.02%. The high price target for ARA is $27.00 and the low price target for ARA is $20.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.673.002.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $23.50$23.50$20.00$20.50
Price Target Upside: 49.02% upside0.09% downside19.05% upside64.13% upside

American Renal Associates (NYSE:ARA) Consensus Price Target History

Price Target History for American Renal Associates (NYSE:ARA)

American Renal Associates (NYSE:ARA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/8/2018Leerink SwannDowngradeOutperform -> Market Perform$17.00 -> $27.00HighView Rating Details
12/21/2017SunTrust BanksSet Price TargetBuy$20.00MediumView Rating Details
5/11/2017Wells FargoUpgradeMarket Perform -> OutperformHighView Rating Details
3/9/2017BarclaysLower Price TargetOverweight$25.00 -> $23.00LowView Rating Details
11/21/2016Goldman SachsDowngradeNeutral -> SellN/AView Rating Details
8/22/2016Bank of AmericaReiterated RatingBuy$35.00N/AView Rating Details
(Data available from 4/24/2016 forward)

Earnings

American Renal Associates (NYSE:ARA) Earnings History and Estimates Chart

Earnings by Quarter for American Renal Associates (NYSE:ARA)

American Renal Associates (NYSE:ARA) Earnings Estimates

2018 EPS Consensus Estimate: $0.74
2019 EPS Consensus Estimate: $0.66
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.05$0.13$0.09
Q2 20182$0.14$0.24$0.19
Q3 20182$0.20$0.24$0.22
Q4 20182$0.22$0.25$0.24
Q1 20191$0.10$0.10$0.10
Q2 20191$0.17$0.17$0.17
Q3 20191$0.19$0.19$0.19
Q4 20191$0.20$0.20$0.20

American Renal Associates (NYSE ARA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/7/2018$0.10N/AView Earnings Details
3/6/2018Q4 2017$0.15$0.18$195.15 million$194.40 millionViewListenView Earnings Details
11/14/2017Q3 2017$0.16$0.19$194.60 million$187.71 millionViewN/AView Earnings Details
8/8/2017Q2 2017$0.12$0.16$188.23 million$185.99 millionViewListenView Earnings Details
5/9/2017Q1 2017$0.1040$0.06$184.67 million$177.00 millionViewListenView Earnings Details
3/7/2017Q4 2016$0.28$0.26$197.84 million$199.11 millionViewListenView Earnings Details
11/10/2016Q316$0.24$0.28$189.73 million$192.96 millionViewN/AView Earnings Details
8/9/2016Q2 2016$0.22$0.26$178.14 million$186.94 millionViewN/AView Earnings Details
5/12/2016Q116$0.16$149.30 million$172.10 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

American Renal Associates (NYSE:ARA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

American Renal Associates (NYSE ARA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 9.60%
Institutional Ownership Percentage: 91.89%
Insider Trading History for American Renal Associates (NYSE:ARA)
Insider Trading History for American Renal Associates (NYSE:ARA)

American Renal Associates (NYSE ARA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/9/2017Jason Allen Ross BrewsterDirectorBuy80,000$0.03$2,400.00
4/26/2016John J McdonoughCOOBuy1,000$22.00$22,000.00262,967View SEC Filing  
4/26/2016Jonathan L WilcoxCFOBuy500$22.00$11,000.003,771View SEC Filing  
4/26/2016Michael Ray CostaVPBuy370$22.00$8,140.00View SEC Filing  
4/2/2015Meyer (Mike) Frederi FlorenceDirectorBuy12,000$0.01$120.00
(Data available from 1/1/2013 forward)

Headlines

American Renal Associates (NYSE ARA) News Headlines

Source:
DateHeadline
 Analysts Anticipate American Renal Associates (ARA) Will Post Quarterly Sales of $189.03 Million Analysts Anticipate American Renal Associates (ARA) Will Post Quarterly Sales of $189.03 Million
www.americanbankingnews.com - April 24 at 2:10 AM
$0.10 EPS Expected for American Renal Associates (ARA) This Quarter$0.10 EPS Expected for American Renal Associates (ARA) This Quarter
www.americanbankingnews.com - April 22 at 7:22 PM
Head-To-Head Comparison: Catasys (CATS) vs. American Renal Associates (ARA)Head-To-Head Comparison: Catasys (CATS) vs. American Renal Associates (ARA)
www.americanbankingnews.com - April 22 at 1:20 PM
American Renal Associates (ARA) Settles Shareholder Derivative LitigationAmerican Renal Associates (ARA) Settles Shareholder Derivative Litigation
www.streetinsider.com - April 21 at 9:32 AM
American Renal Associates Holdings, Inc. Announces Settlement of Shareholder Derivative LitigationAmerican Renal Associates Holdings, Inc. Announces Settlement of Shareholder Derivative Litigation
finance.yahoo.com - April 21 at 9:32 AM
SunTrust Banks Analysts Raise Earnings Estimates for American Renal Associates (ARA)SunTrust Banks Analysts Raise Earnings Estimates for American Renal Associates (ARA)
www.americanbankingnews.com - April 19 at 6:36 AM
Q1 2018 EPS Estimates for American Renal Associates Reduced by SunTrust Banks (ARA)Q1 2018 EPS Estimates for American Renal Associates Reduced by SunTrust Banks (ARA)
www.americanbankingnews.com - April 18 at 7:58 AM
Financial Survey: Caladrius Biosciences (CLBS) and American Renal Associates (ARA)Financial Survey: Caladrius Biosciences (CLBS) and American Renal Associates (ARA)
www.americanbankingnews.com - April 14 at 9:15 PM
Tivity Health (TVTY) and American Renal Associates (ARA) Critical ReviewTivity Health (TVTY) and American Renal Associates (ARA) Critical Review
www.americanbankingnews.com - April 7 at 5:24 PM
American Renal Associates (ARA) PT Set at $18.00 by SunTrust BanksAmerican Renal Associates (ARA) PT Set at $18.00 by SunTrust Banks
www.americanbankingnews.com - April 7 at 12:31 PM
$189.57 Million in Sales Expected for American Renal Associates (ARA) This Quarter$189.57 Million in Sales Expected for American Renal Associates (ARA) This Quarter
www.americanbankingnews.com - April 7 at 2:08 AM
Can Aramus SA. (WSE:ARA) Continue To Outperform Its Industry?Can Aramus SA. (WSE:ARA) Continue To Outperform Its Industry?
finance.yahoo.com - April 3 at 10:02 AM
BRIEF-United Healthcare Insurance Co And United Healthcare Services Files Complaint Against American Renal AssociatesBRIEF-United Healthcare Insurance Co And United Healthcare Services Files Complaint Against American Renal Associates
www.reuters.com - April 2 at 10:11 AM
Analyzing Tivity Health (TVTY) and American Renal Associates (ARA)Analyzing Tivity Health (TVTY) and American Renal Associates (ARA)
www.americanbankingnews.com - April 1 at 5:39 AM
Did American Renal Associates Holdings Inc’s (NYSE:ARA) Earnings Growth Outperform The Industry?Did American Renal Associates Holdings Inc’s (NYSE:ARA) Earnings Growth Outperform The Industry?
finance.yahoo.com - March 29 at 4:16 PM
American Renal Associates Holdings, Inc. Announces Launch of Secondary Public Offering of Common StockAmerican Renal Associates Holdings, Inc. Announces Launch of Secondary Public Offering of Common Stock
finance.yahoo.com - March 26 at 4:09 PM
American Renal Associates (ARA) and Tivity Health (TVTY) Head to Head ContrastAmerican Renal Associates (ARA) and Tivity Health (TVTY) Head to Head Contrast
www.americanbankingnews.com - March 22 at 1:22 AM
$189.90 Million in Sales Expected for American Renal Associates Holdings Inc (ARA) This Quarter$189.90 Million in Sales Expected for American Renal Associates Holdings Inc (ARA) This Quarter
www.americanbankingnews.com - March 21 at 1:08 AM
How Financially Strong Is Aramus SA. (WSE:ARA)?How Financially Strong Is Aramus SA. (WSE:ARA)?
finance.yahoo.com - March 15 at 9:37 AM
How American Renal Associates’ Financial Performance Is TrendingHow American Renal Associates’ Financial Performance Is Trending
finance.yahoo.com - March 12 at 10:33 AM
Leerink Swann Weighs in on American Renal Associates Holdings Incs Q2 2018 Earnings (ARA)Leerink Swann Weighs in on American Renal Associates Holdings Inc's Q2 2018 Earnings (ARA)
www.americanbankingnews.com - March 12 at 3:40 AM
What’s American Renal Associates Holdings’ Growth Strategy?What’s American Renal Associates Holdings’ Growth Strategy?
finance.yahoo.com - March 9 at 5:13 PM
Analyzing the Business Model of American Renal Associates HoldingsAnalyzing the Business Model of American Renal Associates Holdings
finance.yahoo.com - March 9 at 5:13 PM
SunTrust Banks Comments on American Renal Associates Holdings Incs Q1 2018 Earnings (ARA)SunTrust Banks Comments on American Renal Associates Holdings Inc's Q1 2018 Earnings (ARA)
www.americanbankingnews.com - March 9 at 8:04 AM
American Renal Associates Holdings Inc Forecasted to Earn Q1 2018 Earnings of $0.13 Per Share (ARA)American Renal Associates Holdings Inc Forecasted to Earn Q1 2018 Earnings of $0.13 Per Share (ARA)
www.americanbankingnews.com - March 9 at 8:04 AM
American Renal Associates (ARA) Lowered to Market Perform at Leerink SwannAmerican Renal Associates (ARA) Lowered to Market Perform at Leerink Swann
www.americanbankingnews.com - March 8 at 11:40 PM
American Renal Associates (ARA) and Diplomat Pharmacy (DPLO) Critical ReviewAmerican Renal Associates (ARA) and Diplomat Pharmacy (DPLO) Critical Review
www.americanbankingnews.com - March 7 at 9:14 PM
American Renal Associates Holdings, Inc. to Host Earnings CallAmerican Renal Associates Holdings, Inc. to Host Earnings Call
finance.yahoo.com - March 7 at 9:50 AM
American Renal Associates (ARA) Announces  Earnings ResultsAmerican Renal Associates (ARA) Announces Earnings Results
www.americanbankingnews.com - March 6 at 9:12 PM
American Renal Associates Holdings, Inc. Announces Fourth Quarter 2017 ResultsAmerican Renal Associates Holdings, Inc. Announces Fourth Quarter 2017 Results
finance.yahoo.com - March 6 at 4:38 PM
Is American Renal Associates Holdings Inc’s (NYSE:ARA) Balance Sheet A Threat To Its Future?Is American Renal Associates Holdings Inc’s (NYSE:ARA) Balance Sheet A Threat To Its Future?
finance.yahoo.com - March 6 at 4:38 PM
American Renal Associates posts 4Q profitAmerican Renal Associates posts 4Q profit
finance.yahoo.com - March 6 at 4:38 PM
Martingale Asset Management L P Has $1.33 Million Stake in American Renal Associates Holdings Inc (ARA)Martingale Asset Management L P Has $1.33 Million Stake in American Renal Associates Holdings Inc (ARA)
www.americanbankingnews.com - March 6 at 11:56 AM
 Brokerages Expect American Renal Associates Holdings Inc (ARA) Will Post Quarterly Sales of $196.25 Million Brokerages Expect American Renal Associates Holdings Inc (ARA) Will Post Quarterly Sales of $196.25 Million
www.americanbankingnews.com - March 4 at 2:38 AM
American Renal Associates Holdings Inc (ARA) Expected to Post Earnings of $0.15 Per ShareAmerican Renal Associates Holdings Inc (ARA) Expected to Post Earnings of $0.15 Per Share
www.americanbankingnews.com - March 2 at 8:22 PM
American Renal Associates Holdings Inc (ARA) Shares Bought by Altrinsic Global Advisors LLCAmerican Renal Associates Holdings Inc (ARA) Shares Bought by Altrinsic Global Advisors LLC
www.americanbankingnews.com - March 2 at 4:10 AM
American Renal Associates Announces Outstanding Quality and Satisfaction ResultsAmerican Renal Associates Announces Outstanding Quality and Satisfaction Results
finance.yahoo.com - February 27 at 4:51 PM
American Renal Associates (ARA) & MEDNAX (MD) Head-To-Head ReviewAmerican Renal Associates (ARA) & MEDNAX (MD) Head-To-Head Review
www.americanbankingnews.com - February 26 at 1:22 PM
American Renal Associates (ARA) to Release Quarterly Earnings on MondayAmerican Renal Associates (ARA) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - February 26 at 3:20 AM
American Renal Associates (ARA) vs. Streamline Health Solutions (STRM) Head-To-Head ContrastAmerican Renal Associates (ARA) vs. Streamline Health Solutions (STRM) Head-To-Head Contrast
www.americanbankingnews.com - February 21 at 7:13 PM
American Renal Associates (ARA) Upgraded by Zacks Investment Research to HoldAmerican Renal Associates (ARA) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - February 20 at 5:08 PM
American Renal Associates Holdings, Inc. Announces Fourth Quarter 2017 Earnings Release Date and Conference CallAmerican Renal Associates Holdings, Inc. Announces Fourth Quarter 2017 Earnings Release Date and Conference Call
finance.yahoo.com - February 20 at 4:38 PM
 Analysts Expect American Renal Associates Holdings Inc (ARA) Will Announce Quarterly Sales of $196.25 Million Analysts Expect American Renal Associates Holdings Inc (ARA) Will Announce Quarterly Sales of $196.25 Million
www.americanbankingnews.com - February 16 at 1:04 PM
Zacks: Brokerages Anticipate American Renal Associates Holdings Inc (ARA) to Announce $0.15 Earnings Per ShareZacks: Brokerages Anticipate American Renal Associates Holdings Inc (ARA) to Announce $0.15 Earnings Per Share
www.americanbankingnews.com - February 14 at 1:08 AM
Investor Expectations to Drive Momentum within A. O. Smith, Jacobs Engineering Group, Ligand Pharmaceuticals, National CineMedia, American Renal Associates, and Acco Brands — Discovering Underlying Factors of InfluenceInvestor Expectations to Drive Momentum within A. O. Smith, Jacobs Engineering Group, Ligand Pharmaceuticals, National CineMedia, American Renal Associates, and Acco Brands — Discovering Underlying Factors of Influence
finance.yahoo.com - February 12 at 8:56 AM
American Renal Associates (ARA) vs. Cancer Genetics (CGIX) Financial AnalysisAmerican Renal Associates (ARA) vs. Cancer Genetics (CGIX) Financial Analysis
www.americanbankingnews.com - February 9 at 9:10 PM
Critical Contrast: American Renal Associates (ARA) vs. MEDNAX (MD)Critical Contrast: American Renal Associates (ARA) vs. MEDNAX (MD)
www.americanbankingnews.com - February 6 at 9:14 AM
BRIEF-American Renal Associates Settles Shareholder Class Action LitigationBRIEF-American Renal Associates Settles Shareholder Class Action Litigation
www.reuters.com - February 2 at 8:59 AM
American Renal Associates Holdings, Inc. Announces Settlement of Shareholder Class Action LitigationAmerican Renal Associates Holdings, Inc. Announces Settlement of Shareholder Class Action Litigation
finance.yahoo.com - February 1 at 9:04 AM
American Renal Associates (ARA) Lowered to Sell at Zacks Investment ResearchAmerican Renal Associates (ARA) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - January 23 at 5:28 PM

SEC Filings

American Renal Associates (NYSE:ARA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

American Renal Associates (NYSE:ARA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

American Renal Associates (NYSE ARA) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.